
‘Monumental’ and ‘highly meaningful’ advances across solid tumors highlight ESMO program
The ESMO Congress recently took place in Madrid, and presidential symposium sessions highlighted upcoming new standards of care based on several groundbreaking studies. These present a potential change to clinical management for patients with urothelial cancer, lung cancer and colorectal cancer. The studies reviewed the combination of pembrolizumab and enfortumab vedotin, showing remarkable efficacy in…